| Address: |
2110 Rutherford Road Carlsbad, California 92008 |
Organization Profile:
CancerVax Corporation is a privately held biotechnology company focused on the research, development, and commercialization of biological products for the treatment and control of cancer. The Company's lead product candidate, Canvaxin™, is one of a new class of products being developed in the area of specific active immunotherapy, also known as therapeutic cancer vaccines. Canvaxin™ is currently in Phase 3 clinical trials at more than 50 sites worldwide for the treatment of advanced-stage melanoma. The Company has a number of product candidates in research and preclinical development, including a specific active immunotherapy product candidate for lung cancer and several monoclonal antibodies and peptides that target various solid tumor cancers. CancerVax maintains its corporate headquarters and research and development facility in Carlsbad, California, and its biologics manufacturing facility in Los Angeles, California.
|
Contact: Bob Jones E-mail: bjones@cancervax.com Phone: (760) 494-4210 Fax: (760) 494-4271 Home Page Address: www.cancervax.com Number of Employees: 140 |
|
Resource(s) Provided By This Organization:
Tours and Classroom Speakers
